Alfred Lanzafame

550 total citations
15 papers, 440 citations indexed

About

Alfred Lanzafame is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Surgery. According to data from OpenAlex, Alfred Lanzafame has authored 15 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cellular and Molecular Neuroscience and 3 papers in Surgery. Recurrent topics in Alfred Lanzafame's work include Receptor Mechanisms and Signaling (8 papers), Ion channel regulation and function (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Alfred Lanzafame is often cited by papers focused on Receptor Mechanisms and Signaling (8 papers), Ion channel regulation and function (6 papers) and Neuroscience and Neuropharmacology Research (4 papers). Alfred Lanzafame collaborates with scholars based in Australia, France and Japan. Alfred Lanzafame's co-authors include Arthur Christopoulos, F. Mitchelson, Patrick M. Sexton, Albrecht Ziegler, Elizabeth Guida, Lynne Turnbull, Elizabeth A. Woodcock, Jane F. Arthur, Susan R. Davis and Andrew Weekes and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Pharmacology and Molecular Pharmacology.

In The Last Decade

Alfred Lanzafame

13 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alfred Lanzafame Australia 9 345 236 33 27 22 15 440
Joseph A. Beavo United States 8 299 0.9× 148 0.6× 30 0.9× 47 1.7× 22 1.0× 10 456
Delphine S. Dupuis France 14 421 1.2× 339 1.4× 21 0.6× 33 1.2× 6 0.3× 23 529
Amy E. Moritz United States 14 409 1.2× 338 1.4× 16 0.5× 23 0.9× 8 0.4× 24 505
Qin Shan United States 5 197 0.6× 151 0.6× 31 0.9× 25 0.9× 8 0.4× 6 355
Sheila M. Knepper United States 9 306 0.9× 178 0.8× 24 0.7× 90 3.3× 9 0.4× 13 442
Flora Jow United States 17 449 1.3× 228 1.0× 19 0.6× 61 2.3× 11 0.5× 27 573
Claudia Haarmann Australia 17 550 1.6× 262 1.1× 13 0.4× 52 1.9× 25 1.1× 27 654
Julie V. Selkirk United States 12 306 0.9× 291 1.2× 24 0.7× 44 1.6× 4 0.2× 23 497
Francesca Novi Italy 9 421 1.2× 363 1.5× 15 0.5× 27 1.0× 25 1.1× 15 519
M. Pérez Spain 11 273 0.8× 266 1.1× 58 1.8× 61 2.3× 101 4.6× 16 553

Countries citing papers authored by Alfred Lanzafame

Since Specialization
Citations

This map shows the geographic impact of Alfred Lanzafame's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Lanzafame with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Lanzafame more than expected).

Fields of papers citing papers by Alfred Lanzafame

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Lanzafame. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Lanzafame. The network helps show where Alfred Lanzafame may publish in the future.

Co-authorship network of co-authors of Alfred Lanzafame

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Lanzafame. A scholar is included among the top collaborators of Alfred Lanzafame based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Lanzafame. Alfred Lanzafame is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Yamaguchi, Yukie, et al.. (2025). Management of psoriasis in women 18 to 45 years of age in Australia and Japan: insights from patient and dermatologist surveys. International Journal of Women’s Dermatology. 11(1). e189–e189.
2.
3.
Robinson, Penelope J., Robin J. Bell, Alfred Lanzafame, et al.. (2012). Comparison of plain vertebral X‐ray and dual‐energy X‐ray absorptiometry for the identification of older women for fracture prevention in primary care. Internal Medicine Journal. 43(1). 38–45. 2 indexed citations
4.
Robinson, Penelope J., Robin J. Bell, Alfred Lanzafame, et al.. (2011). The prevalence of vitamin D deficiency and relationship with fracture risk in older women presenting in Australian general practice. Australasian Journal on Ageing. 32(3). 177–183. 7 indexed citations
5.
Lanzafame, Alfred, Patrick M. Sexton, & Arthur Christopoulos. (2006). Interaction Studies of Multiple Binding Sites on M4 Muscarinic Acetylcholine Receptors. Molecular Pharmacology. 70(2). 736–746. 26 indexed citations
6.
Lanzafame, Alfred, et al.. (2005). Inositol phospholipids localized to caveolae in rat heart are regulated by α1-adrenergic receptors and by ischemia-reperfusion. American Journal of Physiology-Heart and Circulatory Physiology. 290(5). H2059–H2065. 21 indexed citations
7.
Lanzafame, Alfred & Arthur Christopoulos. (2004). Investigation of the Interaction of a Putative Allosteric Modulator, N-(2,3-Diphenyl-1,2,4-thiadiazole-5-(2 H)-ylidene) Methanamine Hydrobromide (SCH-202676), with M1 Muscarinic Acetylcholine Receptors. Journal of Pharmacology and Experimental Therapeutics. 308(3). 830–837. 44 indexed citations
8.
Lanzafame, Alfred, Elizabeth Guida, & Arthur Christopoulos. (2004). Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors. Biochemical Pharmacology. 68(11). 2207–2219. 19 indexed citations
9.
Lanzafame, Alfred, Arthur Christopoulos, & F. Mitchelson. (2003). Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors. PubMed. 9(4). 241–260. 103 indexed citations
10.
Lanzafame, Alfred, Arthur Christopoulos, & F. Mitchelson. (2003). Cellular Signaling Mechanisms for Muscarinic Acetylcholine Receptors. 9(4). 241–260. 69 indexed citations
11.
Lanzafame, Alfred, Arthur Christopoulos, & F. Mitchelson. (2001). The allosteric interaction of otenzepad (AF-DX 116) at muscarinic M2 receptors in guinea pig atria. European Journal of Pharmacology. 416(3). 235–244. 6 indexed citations
12.
Mitchelson, F., Alfred Lanzafame, & Arthur Christopoulos. (1999). The interaction of otenzepad (AF-DX 116) with allosteric modulators and competitive antagonists at a muscarinic M2 receptor. Life Sciences. 64(6-7). 559–559. 1 indexed citations
13.
Christopoulos, Arthur, Alfred Lanzafame, & F. Mitchelson. (1998). ALLOSTERIC INTERACTIONS AT MUSCARINIC CHOLINOCEPTORS. Clinical and Experimental Pharmacology and Physiology. 25(3-4). 185–194. 96 indexed citations
14.
Christopoulos, Arthur, Alfred Lanzafame, Albrecht Ziegler, & F. Mitchelson. (1997). Kinetic studies of co-operativity at atrial muscarinic m2 receptors with an “infinite dilution” procedure. Biochemical Pharmacology. 53(6). 795–800. 22 indexed citations
15.
Lanzafame, Alfred, Arthur Christopoulos, & F. Mitchelson. (1996). Interactions of agonists with an allosteric antagonist at muscarinic acetylcholine M2 receptors. European Journal of Pharmacology. 316(1). 27–32. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph A. Beavo Breakdown of academic impact, for papers by Delphine S. Dupuis Breakdown of academic impact, for papers by Amy E. Moritz Breakdown of academic impact, for papers by Qin Shan Breakdown of academic impact, for papers by Sheila M. Knepper Breakdown of academic impact, for papers by Flora Jow Breakdown of academic impact, for papers by Claudia Haarmann Breakdown of academic impact, for papers by Julie V. Selkirk Breakdown of academic impact, for papers by Francesca Novi Breakdown of academic impact, for papers by M. Pérez
Rankless by CCL
2026